Credit Suisse’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.82M | Buy |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $836K | Sell |
|
|||||
|
2023
Q2 | $1.74M | Buy |
|
|||||
|
2023
Q1 | $874K | Buy |
|
|||||
|
2022
Q4 | $341K | Sell |
|
|||||
|
2022
Q3 | $270K | Buy |
|
|||||
|
2022
Q2 | $251K | Sell |
|
|||||
|
2022
Q1 | $779K | Buy |
|
|||||
|
2021
Q4 | $969K | Buy |
|
|||||
|
2021
Q3 | $491K | Buy |
|
|||||
|
2021
Q2 | $1.23M | Buy |
|
|||||
|
2021
Q1 | $549K | Sell |
|
|||||
|
2020
Q4 | $1.02M | Buy |
|
|||||
|
2020
Q3 | $537K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $358K | Buy |
|